Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Malaria drug resistance confirmed in Myanmar

26 February 2015

Recent reports suggest that artemisinin drug resistance is emerging and spreading in many parts of the Asian Mekong region.

Location of sampling sites, sample sizes, and administrative states and regions of Myanmar. A relief map of southeast Asia red circles show numbers of patients in each region. Credit: The Lancet Infectious Diseases DOI: (10.1016/S1473-3099(15)70032-0)

A study published today by NDM researchers in Lancet Infectious Diseases reports that the spread of artemisinin drug resistance is following the same historical route as resistance to other antimalarial drugs, chloroquine and sulfadoxine/pyrimethamine.